View Author
antibody virus macaque vaccine measles vaccination mva-fh level animal response vaccinated presence challenge vaccinia plasma infection mv-speci mv-specific protein macaques vaccinated serum rvv-fh intratracheal challenge mv-neutralizing vaccinated macaques mv-neutralizing antibodies absence immunity sample wild-type plasma samples titer wild-type mv cd 69 mv-specific vn antibodies development t-cell number expression 103 tcid 50s mv-speci fic antibodies assay plate virol mac.b-lcl strain vaccinia virus mac.b-lcl cells h glycoproteins h proteins mva-wt erasmus mc attenuated glycoprotein weeks 0 replication van binnendijk candidate vn antibody titers binnendijk study experiment intratracheal osterhau mv vaccination-challenge model f gene mv-specific antibodies erasmus university rotterdam 0.2 0.1 t-cell responses promoter mv-schwarz netherland 37° c institute infant vaccinia virus ankara vaccine-induced immunity vn antibody responses
2 Most Recent Publications
|
Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies
(Article)
Stittelaar, K.J. Wyatt, L.S. Swart, R.L. de Vos, H.W. Groen, J. Amerongen, G. van Binnendijk, R.S. van Rozenblatt, S. Moss, B. Osterhaus, A.D.M.E. |
2000-05-02
|
|
Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies
(Article)
Stittelaar, K.J. Wyatt, L.S. Swart, R.L. de Vos, H.W. Groen, J. Binnendijk, R.S. van Rozenblatt, S. Moss, B. Amerongen, G. van Osterhaus, A.D.M.E. |
2000-01-01
|